BioProtect is a leader in radiation protection technology. We offer spacers protecting healthy tissue during radiation oncology treatments, based on proprietary biodegradable balloon technology.
The balloons suit a wide range of clinical applications in the fields of oncology and general surgery.
The company’s first product, the BioProtect Balloon Implant, protects healthy tissue in patients undergoing radiation therapy for prostate cancer. The balloon spacer enables safe high-dose radiation therapy (including dose escalation and hypofractionation), dramatically decreasing the probability of serious and chronic radiation side effects while improving biochemical tumor control.
The balloons suit a wide range of clinical applications in the fields of oncology and general surgery.
The company’s first product, the BioProtect Balloon Implant, protects healthy tissue in patients undergoing radiation therapy for prostate cancer. The balloon spacer enables safe high-dose radiation therapy (including dose escalation and hypofractionation), dramatically decreasing the probability of serious and chronic radiation side effects while improving biochemical tumor control.
Location: Israel, Center District, Kochav Yair Tzur Yigal
Employees: 11-50
Phone: +972 9-773-1929
Total raised: $20M
Founded date: 2004
Investors 2
| Date | Name | Website |
| - | Triventure... | triventure... |
| - | Precede Te... | precedetec... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 15.01.2020 | - | $13M | - |
| 21.05.2019 | - | $7M | - |
Mentions in press and media 1
| Date | Title | Description |
| 15.01.2020 | BioProtect Raises $13M In Initial Closing of Equity Financing | BioProtect ltd., a Tzur Yigal, Israel-based company developing bioabsorbable polymer spacer balloons, held the initial closing of $13m of its Series D equity financing. The round was led by the family office of Vincent Tchenguiz, chairman o... |